METAMUCIL BERRY BURST! OTC
Generic Name and Formulations:
Psyllium husk 3.4g; per rounded teaspoon; pwd; sugar-free; contains phenylalanine, sodium, potassium.
Procter & Gamble Pharmaceuticals
Indications for METAMUCIL BERRY BURST!:
3.4g of powder in 8oz liquid, or 2 wafers or 5 caps with 8oz liquid 1–3 times daily, or 5 caps plus calcium with 8oz liquid up to 4 times daily. Drink 8 more ounces of liquid after powder. Results in 12–72 hours.
<6yrs: not recommended. 6–11yrs (use powder or wafer): 1.7g of powder in 8oz liquid, or 1 wafer with 8oz liquid 1–3 times daily. Drink 8 more ounces of liquid after powder.
Signs/symptoms of appendicitis. Intestinal obstruction. Fecal impaction. Dysphagia.
Rectal bleeding. Esophageal narrowing. Diabetes (sugar-containing forms).
Separate dosing by at least 2 hours from other medications.
Esophageal, gastric, enteral, rectal obstruction.
Pwd—48, 72, 114, 180, 220 doses; Pwd packets—30; Wafers—24; Caps—100, 160, 300; Caps + calcium—75, 120
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Patent Foramen Ovale Closure for Stroke Prevention: Key Principles for Clinical Practice
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Population-Based Incidence of Acute Idiopathic Optic Neuritis Estimated
- First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR
- High Anxiety Symptoms Prevalent in Epilepsy, Mesial Temporal Sclerosis
- Advance Care Planning Doesn't Aid Quality of Life
- Variation in Specialty Drug Coverage Across Health Plans